HIGHLIGHTS
- who: Daisuke Ikeda and colleagues from the Department of Hematology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan have published the paper: Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors, in the Journal: (JOURNAL)
- what: The authors focus on the biological background and real-world etiology of these adverse genetic factors and then describe a strategy to overcome the clinical disadvantages in terms of targeting pivotal molecular mechanisms. The ad hoc analysis of the AML201 study focused 8 of 22 on 197 patients in which comprehensive genetic data were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.